Delivery Order SPE2DB24D2101-SPE2DB25FKPYE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of PROMACTA 25 MG tablets in quantities of 30 units, with a ceiling value of $8,836.12. This is a firm fixed price delivery order with an ultimate completion date of July 11, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $16,053.06, represents a non-set-aside competitive award with an ultimate completion date of September 22, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,029.63 to supply Promacta 75 mg tablets (30-count units) with a completion deadline of May 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on April 24, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- The Defense Logistics Agency awarded a $24,059.26 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of October 9, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $8,026.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of PROMACTA 50 MG tablets in units of 30s. The contract, which is not set-aside and competitively awarded, has an ultimate completion date of September 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for PROMACTA 50 mg tablets in packages of 30 units. This firm fixed-price delivery order, valued at $8,026.53, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by August 14, 2025. The award leverages AmerisourceBergen's established relationship as a critical pharmaceutical vendor within the federal medical...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for PROMACTA 50 MG tablets (30-count units) valued at $8,026.53 on August 27, 2025, with completion targeted for September 18, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $13,254.18 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Promacta 25 mg tablets (30-count unit of use packaging). This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is scheduled for completion by October 1, 2025. The award is performance-based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order has a ceiling value of $8,026.53 with a firm fixed price structure and an ultimate completion date of September 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $26,503.50 to AmerisourceBergen Drug Corp for the supply of Promacta 12.5 mg tablets in quantities of 30 units. This firm fixed price contract, awarded on May 22, 2025, with an ultimate completion date of June 13, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPYEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,251.75 to AmerisourceBergen Drug Corp for the supply of PROMACTA 12.5 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor within the federal medical supply chain. This delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As the prime contractor for this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive contract portfolio demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 9/24/25 |